← Browse by Condition
Medical Condition
advanced ccne1 amplified solid tumors
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT06726148 Phase 1, Phase 2
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Enrollment
280 pts
Location
United States, Austr...
Sponsor
Novartis Pharmaceuticals
NCT07288359 Phase 1, Phase 2
Recruiting
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Enrollment
205 pts
Location
United States, Japan...
Sponsor
Novartis Pharmaceuticals